Clinical Trial: A Study on the Tolerability, Safety and Effectiveness of Asciminib in Patients With Philadelphia Chromosome-positive Chronic Myeloid Leukemia in the Chronic Phase in Germany

U.S., April 25 -- ClinicalTrials.gov registry received information related to the study (NCT07549516) titled 'A Study on the Tolerability, Safety and Effectiveness of Asciminib in Patients With Philadelphia Chromosome-positive Chronic Myeloid Leukemia in the Chronic Phase in Germany' on April 16.

Brief Summary: The aim of this study is to assess the real-world effectiveness of asciminib in Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase (Ph+ CML-CP) patients who were either newly diagnosed or previously treated with one ATP-competitive tyrosine kinase inhibitor (TKI).

Study Start Date: April 17

Study Type: OBSERVATIONAL

Condition: Leukemia, Chronic Myeloid

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Nov...